School of Public Health, University at Albany, State University of New York, Rensselaer, New York.
Cardiac Surgical Division, Massachusetts General Hospital, Boston, Massachusetts.
J Am Coll Cardiol. 2019 Sep 10;74(10):1275-1285. doi: 10.1016/j.jacc.2019.06.067.
Despite recent guideline statements, there is still wide practice variation in the use of multiple arterial grafts (MAGs) versus single arterial grafts (SAGs) for patients with multivessel disease undergoing coronary artery bypass graft surgery. This may be related to differences in findings between observational and randomized controlled studies.
This study sought to compare intermediate-term MAG and SAG outcomes with enhanced matching to reduce selection bias.
New York's cardiac registry identified 63,402 multivessel disease patients undergoing coronary artery bypass graft surgery between January 1, 2005, and December 31, 2014, to compare outcomes (median follow-up 6.5 years) for patients receiving SAGs and MAGs. SAG and MAG patients were propensity matched using 38 baseline characteristics to reduce selection bias. The primary endpoint was mortality, and secondary endpoints included repeat revascularization and a composite endpoint of mortality, acute myocardial infarction, and stroke.
Before matching, 20% of procedures employed MAG. At 1 year, there was no mortality difference between matched MAG and SAG patients (2.4% vs. 2.2%, adjusted hazard ratio [AHR]: 1.11; 95% confidence interval [CI]: 0.93 to 1.32). At 7 years, MAG patients had lower mortality (12.7% vs. 14.3%, AHR: 0.86; 95% CI: 0.79 to 0.93), a lower composite outcome (20.2% vs. 22.8%, AHR: 0.88; 95% CI: 0.83 to 0.93), and a lower repeat revascularization rate (11.7% vs. 14.6%, AHR: 0.80; 95% CI: 0.74 to 0.87). At 7 years, the subgroups for which MAG did not have a lower mortality rate included patients with off-pump surgery, 2-vessel disease with right coronary artery disease, recent acute myocardial infarction, renal dysfunction, and patient ≥70 years of age.
Mortality and the composite outcome were similar between MAG and SAG patients at 1 year, but lower for MAG after 7 years. Patients of higher volume MAG surgeons experienced lower MAG mortality.
尽管最近的指南声明指出,对于接受冠状动脉旁路移植术的多血管疾病患者,使用多个动脉移植物(MAG)与单个动脉移植物(SAG)的做法仍存在广泛差异。这可能与观察性研究和随机对照研究之间的结果差异有关。
本研究旨在通过增强匹配以减少选择偏倚,比较中期 MAG 和 SAG 的结果。
纽约心脏登记处确定了 2005 年 1 月 1 日至 2014 年 12 月 31 日期间接受冠状动脉旁路移植术的 63402 例多血管疾病患者,以比较接受 SAG 和 MAG 患者的结果(中位随访 6.5 年)。使用 38 个基线特征对 SAG 和 MAG 患者进行倾向匹配,以减少选择偏倚。主要终点为死亡率,次要终点包括再次血运重建和死亡率、急性心肌梗死和卒中等复合终点。
在匹配之前,20%的手术采用 MAG。在 1 年时,匹配后的 MAG 和 SAG 患者之间的死亡率没有差异(2.4%对 2.2%,调整后的危险比 [AHR]:1.11;95%置信区间 [CI]:0.93 至 1.32)。在 7 年时,MAG 患者的死亡率较低(12.7%对 14.3%,AHR:0.86;95%CI:0.79 至 0.93),复合结局较低(20.2%对 22.8%,AHR:0.88;95%CI:0.83 至 0.93),再次血运重建率较低(11.7%对 14.6%,AHR:0.80;95%CI:0.74 至 0.87)。在 7 年时,MAG 未降低死亡率的亚组包括非体外循环手术、2 支血管疾病伴右冠状动脉疾病、近期急性心肌梗死、肾功能不全和年龄≥70 岁的患者。
在 1 年时,MAG 和 SAG 患者的死亡率和复合结局相似,但 7 年后 MAG 的死亡率较低。MAG 手术量较高的患者的 MAG 死亡率较低。